FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis
S. Preisendörfer (Munich, Germany), Y. Ishikawa (San Francisco, United States of America), L. Knüppel (Munich, Germany), I. Fernandez (Munich, Germany), L. Binzenhöfer (Munich, Germany), B. Juan-Guardela (Yale, United States of America), E. Hennen (Munich, Germany), C. Ruppert (Gießen, Germany), A. Guenther (Gießen, Germany), N. Kneidinger (Munich, Germany), M. Frankenberger (Munich, Germany), R. Hatz (Munich, Germany), J. Behr (Munich, Germany), A. Schepers (Munich, Germany), A. Hilgendorff (Munich, Germany), N. Kaminski (Yale, United States of America), H. Bächinger (Portland, United States of America), O. Eickelberg (Denver, United States of America), C. Staab-Weijnitz (Munich, Germany)
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Preisendörfer (Munich, Germany), Y. Ishikawa (San Francisco, United States of America), L. Knüppel (Munich, Germany), I. Fernandez (Munich, Germany), L. Binzenhöfer (Munich, Germany), B. Juan-Guardela (Yale, United States of America), E. Hennen (Munich, Germany), C. Ruppert (Gießen, Germany), A. Guenther (Gießen, Germany), N. Kneidinger (Munich, Germany), M. Frankenberger (Munich, Germany), R. Hatz (Munich, Germany), J. Behr (Munich, Germany), A. Schepers (Munich, Germany), A. Hilgendorff (Munich, Germany), N. Kaminski (Yale, United States of America), H. Bächinger (Portland, United States of America), O. Eickelberg (Denver, United States of America), C. Staab-Weijnitz (Munich, Germany). FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis. 2293
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010
Expression of the Bcl-2 binding protein beclin 1 in human idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011
Increased expression of Lysosomal-associated membrane protein 1 (LAMP-1) found in small airway epithelium of COPD may have functional consequence and role in autophagy. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017
A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018
MAV(S)erick mitochondria: an unconventional role for mitochondrial antiviral signalling protein in pulmonary fibrosis Source: Eur Respir J, 57 (4) 2004500; 10.1183/13993003.04500-2020 Year: 2021
NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021
An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13 Source: Eur Respir J, 54 (1) 1802041; 10.1183/13993003.02041-2018 Year: 2019
Homeodomain-interracting protein kinase 2 (HIPK2) in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
RhoA signalling influences cyclin D1 expression and associated fibroblast turnover: implications for idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006
The potential role of intracellular heat shock protein 70 deficiency in aging and pulmonary fibrosis. Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017
Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred Source: Eur Respir J 2011; 38: 861-869 Year: 2011
Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013
IL-18 binding protein as a noble biomarker for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020
Expression and function of a novel membrane-spanning protein, MS4A8B, in the human airways Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015
PP208 – SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021
Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005